Analysis of effects of trastuzumab assisted modified DOF fortnightly regimen on serum tumor markers and survival rate in patients with cisplatin-resistant gastric cancer
Background and purpose: Trastuzumab has a relatively low incidence of drug resistance, which can be used as an adjuvant treatment to improve clinical efficacy. It has been used to treat breast cancer in the past, but its application in other cancers has been less studied. This study aimed to explore...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Office of China Oncology
2024-03-01
|
Series: | Zhongguo aizheng zazhi |
Subjects: | |
Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1712563079944-362336722.pdf |